Covestor’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-34
Closed – – 2520
2026
Q2
$0 Buy
34
+18
+113% +$175 ﹤0.01% 2591
2026
Q1
$0 Hold
16
– – ﹤0.01% 2421
2025
Q4
$0 Hold
16
– – ﹤0.01% 2403
2025
Q3
$0 Hold
16
– – ﹤0.01% 2433
2025
Q2
$0 Sell
16
-1
-6% -$4 ﹤0.01% 2376
2025
Q1
$0 Buy
17
+9
+113% +$42 ﹤0.01% 2385
2024
Q4
$0 Buy
8
+1
+14% +$8 ﹤0.01% 2396
2024
Q3
$0 Buy
7
+3
+75% +$50 ﹤0.01% 2380
2024
Q2
$0 Hold
4
– – ﹤0.01% 2396
2024
Q1
$0 Buy
+4
New +$102 ﹤0.01% 2393

Other funds holding FDMT

Covestor's FDMT Position: Q3 2026 in Review

Covestor sold out of 4D Molecular Therapeutics (FDMT) in Q3 2026, closing a stake of 34 shares.

Covestor first reported a position in FDMT in Q1 2024 and held it in 10 quarters. The position peaked at $0 in Q2 2026. 110 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.

  • Covestor reported no remaining 4D Molecular Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Covestor sold 34 4D Molecular Therapeutics shares in Q3 2026.
  • Covestor first reported a position in 4D Molecular Therapeutics in Q1 2024 and held it in 10 quarters.
  • Covestor's 4D Molecular Therapeutics position peaked at $0 in Q2 2026.
  • 110 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.